FL
GILD icon

FreeGulliver LLC’s Gilead Sciences GILD Stock Holding History

FreeGulliver LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Buy
1,843
+31
+2% +$4.34K 0.11% 86
2025
Q4 		$222K Sell
1,812
-7
-0.4% -$851 0.08% 89
2025
Q3 		$202K Buy
+1,819
New +$207K 0.09% 89

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

FreeGulliver LLC's GILD Position: Q1 2026 in Review

FreeGulliver LLC increased its Gilead Sciences (GILD) stake by 1.7% in Q1 2026, buying an estimated $4.34K and bringing the position to 1,843 shares worth $257K. The position accounts for 0.11% of the portfolio, ranked #86.

FreeGulliver LLC first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • FreeGulliver LLC held 1,843 shares of Gilead Sciences worth $257K as of Q1 2026.
  • FreeGulliver LLC bought 31 Gilead Sciences shares in Q1 2026, an estimated $4.34K.
  • Gilead Sciences made up 0.11% of FreeGulliver LLC's portfolio in Q1 2026, its #86 holding.
  • FreeGulliver LLC first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on FreeGulliver LLC's 13F filing for Q1 2026, filed 15 May 2026.